Toward platelet-count–adaptive anticoagulation in cancer thrombocytopenia: a standards-first, equity-aware proposal
Journal of Thrombosis and Thrombolysis · 2026
DOI: 10.1007/s11239-026-03243-1 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Thrombosis and Thrombolysis, 2026. Verfasst von M Vijayasimha. Beteiligte Einrichtung: Department of Medical Laboratory Technology, University Institute of Allied Health Sciences, Chandigarh University, Mohali, 140413, Punjab, India. vi…. Hauptthemen laut MEDLINE: Anticoagulants, Neoplasms, Thrombocytopenia, Thrombosis. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Cancer-associated thrombosis (CAT) with thrombocytopenia (TP) poses concurrent risks of bleeding and recurrence. Guidance is fragmented by nonuniform platelet thresholds, tumor-context effects on agent choice, and scarce prospective data for DOACs specifically in TP. We outline a platelet-count-adaptive framework: (i) standardized platelet bands linked to dose/agent actions; (ii) tumor-biology-aware selection; (iii) transfusion-sparing triggers; and (iv) a core outcome set that indexes events to time spent within platelet bands ("platelet-adjusted bleeding rate"). The schema is evidence-aligned, feasible in resource-constrained settings, and offers testable standards for pragmatic trials. Translating recent syntheses into implementable, equity-aware standards can reduce unwarranted variation and accelerate learning across diverse care settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Laboratory Technology, University Institute of Allied Health Sciences, Chandigarh University, Mohali, 140413, Punjab, India. vijaya.e19133@cumail.in.
Zitieren
APA
Vijayasimha, M. (2026). Toward platelet-count–adaptive anticoagulation in cancer thrombocytopenia: a standards-first, equity-aware proposal. Journal of Thrombosis and Thrombolysis. https://doi.org/10.1007/s11239-026-03243-1
Vancouver
Vijayasimha M. Toward platelet-count–adaptive anticoagulation in cancer thrombocytopenia: a standards-first, equity-aware proposal. Journal of Thrombosis and Thrombolysis. 2026. doi:10.1007/s11239-026-03243-1
BibTeX
@article{Vijayasimha2026,
author = {Vijayasimha, M},
title = {Toward platelet-count–adaptive anticoagulation in cancer thrombocytopenia: a standards-first, equity-aware proposal},
journal = {Journal of Thrombosis and Thrombolysis},
year = {2026},
doi = {10.1007/s11239-026-03243-1}
}
EUVIMED